Western blot assays are a labor intensive, low throughput, time-consuming, and non-quantitative approach to detecting protein biomarkers.

Projects that are difficult or impossible with western blotting technology can be easily accomplished with our platform. We provide highly sensitive and quantitative results in a fraction of the time, using less sample, and with fewer processing steps.

• Our platform lets you generate complex drug inhibition profiles in far less time than it takes to complete a western blot.
• You can directly transfer cell lysates from 96- or 384-well culture dishes to our microplate-based assays.
• Our immunoassays capture proteins in their native configuration,  while western blotting typically requires denaturing the protein first.
• Processing western blots is complicated, labor-intensive, and prone to operator error. Our assays are fast and simple, and our instruments produce quantitative results in as little as 70 seconds for an entire microtiter plate.
• Western blot assays can provide semi-quantitative results but require expensive imaging systems to do so.